The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
There is a trend of inadequately trained clinicians performing interventional procedures. This trend can potentially lead to serious complications and inappropriate utilization. A comprehensive assessment by a skilled pain specialist is necessary to identify which procedure is indicated for a given patient’s pain syndrome. Unfortunately, pain specialists are typically not involved in the multidisciplinary approaches of diagnosing and treating a pain patient early enough in his or her treatment, which can lead to suboptimal patient outcomes.
The activity was developed to address two emerging gaps:
According to consensus practice guidelines published April 2020 by the American Society of Regional Anesthesia: The past two decades have witnessed a surge in the use of lumbar facet blocks and radiofrequency ablation (RFA) to treat low back pain (LBP), yet nearly all aspects of the procedures remain controversial. The committee determined that lumbar medial branch radiofrequency ablation (RFA) may provide benefit to well-selected individuals, with medial branch blocks (MBB) being more predictive than itra-articular (IA) injections. And that more stringent selection criteria are likely to improve denervation outcomes, but at the expense of more false-negatives.
In 2021, the American College of Radiology Committee on Drugs and Contrast Media of the ACR Commission on Quality and Safety updated the ACR Manual on Contrast Media. In addition to general safety updates, an entire chapter was added to address Nephrogenic systemic fibrosis (NSF). It is now generally accepted that gadolinium-based contrast agent (GBCA) exposure is a necessary factor in the development of NSF.
Outline
Interventions for Lumbar Facet Joint Pain, & Use of Contrast Agents in Interventional Pain Procedures
As a result of participating in this activity, learners will be able/better able to:
Pain management domains and core competencies
Release date: This activity was released 8/28/2021.
Termination date: The content of this activity remains eligible for CME Credit until 8/27/2024, unless reviewed or amended prior to this date.
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this other activity (blended learning) for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest
[Presenter] Scott Pritzlaff discloses the following financial relationships within the past 24 months: Consulting: SPR Therapeutics, EBT Medical, Nalu Medical
No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).
You must be logged in and own this session in order to post comments.
Neurovations Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Neurovations Education designates this other activity (blended learning) for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Financial Relationships & Measures to Resolve of Conflicts of Interest
[Presenter] Scott Pritzlaff discloses the following financial relationships within the past 24 months: Consulting: SPR Therapeutics, EBT Medical, Nalu Medical
No other person with control of, or responsibility for, the planning, delivery, or evaluation of accredited continuing education has, or has had within the past 24 months, financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships have been mitigated. Materials were reviewed in advance of the activity by person(s) that do not have conflicts of interest related to the content. In some cases, content may have been modified as part of the review and mitigation process. All clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).